Category Archives: Strategy

Unmet Need in the Migraine Space?

Allergan CEO David Pyott is bullish on Botox’s potential as a salve for chronic migraine. He’s also betting on a next-gen dihydroergotamine (DHE) – Levadex – from MAP Pharmaceuticals.
Also posted in FDA, Global, Marketing, Regulatory, Technology | Tagged , , , , | 2 Comments

HBA 2012 Woman of the Year: Thinking Beyond the Box

The Healthcare Businesswomen’s Association (HBA) has announced that its 2012 Woman of the Year (WOTY) is Carolyn Buck Luce, global pharmaceutical sector leader at Ernst & Young.  She will be honored at the HBA’s annual Woman of the Year luncheon on May 3 in New York – the 23rd recipient from an organization that has set the pace in [...]
Posted in Strategy | Leave a comment

Sales Rep vs. eDetail: Consider the Practice Area

Forget illegal immigrants, it is machines that are stealing American jobs. For some medical practice areas, however, digital details haven’t sufficiently stepped in where their human sales rep predecessors have stepped (or have been pushed) out, according to a survey of U.S. physicians.
Also posted in Advertising, E-Media, Marketing, Sales | Tagged , , | 1 Comment

JP Morgan Healthcare Conference Marked by Uncertainty

2012 J.P. Morgan Healthcare Conference Marked by Uncertainty Audrey S. Erbes, Principal, Erbes & Associates, outlines the highlights of this week’s event in San Francisco. One of the few positive notes struck in this week’s 30th Annual J.P. Morgan Healthcare Conference (held in San Francisco) was the announcement by Kevin Willsey, J.P. Morgan’s co-head of investment banking [...]
Also posted in Guest Blog, R&D, healthcare | Tagged , , , , | 2 Comments

Humana CEO: Keep People Out of Hospitals

Outgoing CEO Michael McCallister said one of Humana’s primary strategies going forward is to keep patients out of hospitals and other healthcare institutions, when possible.
Posted in Strategy | Leave a comment